Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 22526380)

Published in Heart Vessels on April 19, 2012

Authors

Hidetoshi Hattori1, Yuichiro Minami, Masayuki Mizuno, Dai Yumino, Hiromi Hoshi, Hiroyuki Arashi, Toshiaki Nuki, Yukiko Sashida, Michiaki Higashitani, Naoki Serizawa, Norihiro Yamada, Junichi Yamaguchi, Fumiaki Mori, Tsuyoshi Shiga, Nobuhisa Hagiwara

Author Affiliations

1: Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Articles cited by this

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J (2008) 12.32

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10

Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation (1984) 5.60

Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol (1990) 4.10

Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA (2005) 3.51

Acute heart failure syndromes. J Am Coll Cardiol (2009) 2.91

Acute heart failure syndromes: current state and framework for future research. Circulation (2005) 2.47

Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun (1984) 2.40

Determination of cardiac output by Doppler echocardiography. Br Heart J (1984) 2.31

Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol (1989) 1.62

Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation (1987) 1.58

Natriuretic peptides and therapeutic applications. Heart Fail Rev (2007) 1.44

Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study. Circ J (2008) 1.29

Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol (2005) 1.27

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol (2001) 1.14

Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy. Circ J (2005) 1.11

Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study. Circ J (2008) 1.02

Definition and epidemiology of acute heart failure syndromes. Am J Cardiol (2005) 0.99

Echocardiographic assessment of right heart hemodynamic parameters. J Am Soc Echocardiogr (2007) 0.95

Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction. Heart Vessels (2010) 0.91

Prospective Doppler echocardiographic evaluation of pulmonary artery diastolic pressure in the medical intensive care unit. Am J Cardiol (1989) 0.88

Prognostic implications of echocardiography in advanced heart failure. Curr Opin Cardiol (2004) 0.86

Efficacy and safety of nicorandil therapy in patients with acute heart failure. J Cardiol (2010) 0.84

An introduction to acute heart failure syndromes: definition and classification. Heart Fail Rev (2007) 0.81

Elevated troponin T on discharge predicts poor outcome of decompensated heart failure. Heart Vessels (2010) 0.81

Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure. J Cardiol (2010) 0.81

Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels (2010) 0.81

Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients. J Am Coll Cardiol (1997) 0.80

Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation. J Cardiovasc Pharmacol (2009) 0.80

Echocardiographic predictors of change in left ventricular diastolic pressure in heart failure patients receiving nesiritide. Echocardiography (2008) 0.79

Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans. J Cardiovasc Pharmacol (1992) 0.79

Systolic blood pressure at admission as a predictor of the response to initial carperitide therapy in patients hospitalized for acute decompensated heart failure with left ventricular systolic dysfunction. Cardiovasc Drugs Ther (2009) 0.78

Acute efficacy of combined therapy of carperitide and nicorandil for acute decompensated heart failure with left ventricular systolic dysfunction. Int J Cardiol (2009) 0.77

Acute hemodynamic effects of alpha human atrial natriuretic polypeptide in patients with congestive heart failure. Jpn Heart J (1988) 0.77

Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction. Am J Cardiol (1998) 0.76

Articles by these authors

Contrasting effects of lower body positive pressure on upper airways resistance and partial pressure of carbon dioxide in men with heart failure and obstructive or central sleep apnea. J Am Coll Cardiol (2013) 2.64

Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. Am J Respir Crit Care Med (2008) 2.29

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain (2007) 2.10

Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest (2009) 1.69

Obstructive sleep apnea is associated with greater thoracic aortic size. J Am Coll Cardiol (2008) 1.68

CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.61

Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE). Eur Heart J (2009) 1.58

CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism. Circulation (2012) 1.53

Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syndrome. J Cardiovasc Electrophysiol (2005) 1.52

The role of echocardiography in predicting responders to cardiac resynchronization therapy. Circ J (2011) 1.49

Targeted endomyocardial biopsy using electroanatomical voltage mapping in the early stage of arrhythmogenic right ventricular cardiomyopathy. Europace (2009) 1.49

Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: a 2-year longitudinal study. Pacing Clin Electrophysiol (2010) 1.48

Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol (2006) 1.47

Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma. Hepatol Res (2014) 1.46

Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol (2007) 1.44

Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy. Europace (2009) 1.43

Long-term nitrate use in acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology nitrate evaluation program). Cardiovasc Drugs Ther (2008) 1.41

Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J (2010) 1.40

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure - A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Circ J (2016) 1.40

Effect of Hemodialysis on 7-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation. Circ J (2015) 1.40

Diagnosis and Detection of Myocardial Injury in Active Cardiac Sarcoidosis - Significance of Myocardial Fatty Acid Metabolism and Myocardial Perfusion Mismatch. Circ J (2015) 1.39

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology (2007) 1.36

Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes (2005) 1.30

Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol (2002) 1.29

Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol (2009) 1.25

Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2011) 1.24

Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A (2011) 1.23

Defective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor. J Cell Biol (2004) 1.22

Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone. Circ J (2007) 1.22

Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (2005) 1.21

TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol (2007) 1.18

NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol (2006) 1.14

Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol (2010) 1.14

Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A. Infect Immun (2010) 1.13

Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett (2009) 1.12

Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J (2013) 1.10

Myocardial fat at cardiac imaging: how can we differentiate pathologic from physiologic fatty infiltration? Radiographics (2010) 1.08

TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol Dis (2010) 1.08

Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death. J Biol Chem (2008) 1.07

Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J (2012) 1.07

A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. J Am Coll Cardiol (2011) 1.06

Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice. Acta Neuropathol (2010) 1.06

The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein. PLoS One (2011) 1.06

Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice. Atherosclerosis (2009) 1.04

The Lewy body in Parkinson's disease and related neurodegenerative disorders. Mol Neurobiol (2012) 1.03

Telmisartan induces proliferation of human endothelial progenitor cells via PPARgamma-dependent PI3K/Akt pathway. Atherosclerosis (2008) 1.03

A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg (2002) 1.02

Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease. Circ J (2015) 1.02

Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol (2008) 1.01

Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43. Neurosci Lett (2008) 1.01

Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commun (2012) 1.01

Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol (2004) 1.00

Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir Physiol Neurobiol (2008) 1.00

Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting. Cardiovasc Drugs Ther (2004) 0.98

Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am J Respir Crit Care Med (2002) 0.98

Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy. Int J Cardiol (2008) 0.97

Unusual "ratchet syndrome": spontaneous lead retraction after a generator exchange. Heart Vessels (2013) 0.97

Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1. Cell Microbiol (2007) 0.97

Hippocampal sclerosis with four-repeat tau-positive round inclusions in the dentate gyrus: a new type of four-repeat tauopathy. Acta Neuropathol (2009) 0.95

Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry). Am J Cardiol (2013) 0.95

An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. J Vasc Surg (2002) 0.94

Difference in upper airway collapsibility during wakefulness between men and women in response to lower-body positive pressure. Clin Sci (Lond) (2009) 0.93

Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials (2011) 0.93

Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells. PLoS One (2011) 0.93

Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol (2001) 0.93

Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA. Neurosci Res (2007) 0.93

Rhabdoid cystic papillary meningioma with diffuse subarachnoid dissemination. Acta Neuropathol (2005) 0.92

A connexin40 mutation associated with a malignant variant of progressive familial heart block type I. Circ Arrhythm Electrophysiol (2012) 0.91

Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol (2002) 0.91

Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions. Neuropathology (2011) 0.90

Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol Dis (2011) 0.90

A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease. Circ J (2016) 0.90

Abnormalities of stromal structure in the bullous keratopathy cornea identified by second harmonic generation imaging microscopy. Invest Ophthalmol Vis Sci (2012) 0.89

Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy. Acta Neuropathol (2012) 0.89

Incidental Lewy body disease restricted to the heart and stellate ganglia. Mov Disord (2009) 0.89

Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation. Int J Cardiol (2011) 0.89

p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. J Neurosci Res (2012) 0.88

Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication. Acta Neuropathol (2008) 0.88

Retinoic acid-inducible gene-I is constitutively expressed and involved in IFN-gamma-stimulated CXCL9-11 production in intestinal epithelial cells. Immunol Lett (2009) 0.88

Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases. J Neuropathol Exp Neurol (2013) 0.88

Transverse shifting of the esophagus according to the patient's position helped achieve a safe and successful pulmonary vein isolation procedure. Heart Vessels (2009) 0.88

Clinical characteristics and outcome of hospitalized patients with congestive heart failure: results of the HIJC-HF registry. Circ J (2008) 0.87